MAPT and Mental deterioration: The aim of this study was to investigate whether in patients with SCD and MCI there is an additive effect of CVD and Aβ on neurodegeneration measured by total tau (t-tau) and phosphorylated tau (p-tau) in CSF and medial temporal lobe atrophy (MTA) visualized by MRI, as well as on cognitive decline during follow-up.